Symptomatic hypocalcemia in primary hyperaldosteronism: a case report. 2009

Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
Department of Medicine, Kasturba Medical College, Manipal, Karnataka, India. sachingpai@gmail.com

The metabolic alterations caused by hyperaldosteronism are being increasingly recognized and have generated considerable interest among the medical fraternity. Hyperaldosteronism is suspected to have a pivotal role in the patho-physiology of congestive cardiac failure where it has been studied extensively. But its effects on calcium metabolism, parathyroid metabolism and renal handling of calcium are less well described. Recent experimental models have shed light into the roles played by previously unknown mechanisms in causing these metabolic alterations. We hereby report a case of primary hyperaldosteronism due to adrenal adenoma (Conn's syndrome) who presented with a myriad of clinical features including symptomatic hypocalcemia, significant weight loss along with uncontrolled hypertension for a prolonged period before eventually detected to have primary hyperaldosteronism. Surgical removal of the causative tumor resulted in prompt disappearance of all the symptoms and signs and regain of lost weight.

UI MeSH Term Description Entries
D006996 Hypocalcemia Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed) Hypocalcemias
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000306 Adrenal Cortex Neoplasms Tumors or cancers of the ADRENAL CORTEX. Adrenocortical Cancer,Cancer of Adrenal Cortex,Adrenal Cortex Cancer,Cancer of the Adrenal Cortex,Neoplasms, Adrenal Cortex,Adrenal Cortex Cancers,Adrenal Cortex Neoplasm,Adrenocortical Cancers,Cancer, Adrenal Cortex,Cancer, Adrenocortical,Cancers, Adrenal Cortex,Cancers, Adrenocortical,Neoplasm, Adrenal Cortex
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D018246 Adrenocortical Adenoma A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Adenoma, Adrenal Cortical,Conn's Disease,Adenoma, Adrenocortical,Conn Adenoma,Conn Disease,Adenoma, Conn,Adenomas, Adrenal Cortical,Adenomas, Adrenocortical,Adenomas, Conn,Adrenal Cortical Adenoma,Adrenal Cortical Adenomas,Adrenocortical Adenomas,Conn Adenomas,Conns Disease,Disease, Conn,Disease, Conn's

Related Publications

Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
January 1977, Medicinski arhiv,
Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
January 1979, Archivio per le scienze mediche,
Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
April 1996, The Journal of reproductive medicine,
Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
January 1975, Annali dell'Ospedale Maria Vittoria di Torino,
Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
January 2024, International journal of endocrinology and metabolism,
Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
January 1966, Polskie Archiwum Medycyny Wewnetrznej,
Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
March 2006, The journal of ECT,
Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
February 2023, Cureus,
Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
July 2017, Acta medica Indonesiana,
Sachin G Pai, and K N Shivashankara, and V Pandit, and S Sheshadri
January 2022, The Pan African medical journal,
Copied contents to your clipboard!